The FDA is the US federal agency responsible for approving new drugs. Rejected Lykos Therapeutics' MDMA-assisted therapy NDA in August 2024 via Complete Response Letter. Has cleared INDs for multiple psychedelic research programs including Compass Pathways' COMP360 for PTSD.